These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9524796)

  • 1. Regional hypometabolism related to language disturbance in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Yamashita H; Takatsuki Y; Sasaki M
    Dement Geriatr Cogn Disord; 1998; 9(2):68-73. PubMed ID: 9524796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disconnection and cerebral metabolism. The case of conduction aphasia.
    Kempler D; Metter EJ; Jackson CA; Hanson WR; Riege WH; Mazziotta JC; Phelps ME
    Arch Neurol; 1988 Mar; 45(3):275-9. PubMed ID: 3257689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
    Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of poststroke aphasia studied with positron emission tomography.
    Karbe H; Kessler J; Herholz K; Fink GR; Heiss WD
    Arch Neurol; 1995 Feb; 52(2):186-90. PubMed ID: 7848129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
    Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at onset and regional cerebral glucose metabolism in Alzheimer's disease.
    Yasuno F; Imamura T; Hirono N; Ishii K; Sasaki M; Ikejiri Y; Hashimoto M; Shimomura T; Yamashita H; Mori E
    Dement Geriatr Cogn Disord; 1998; 9(2):63-7. PubMed ID: 9524795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and regional cortical glucose metabolism in patients with Alzheimer's disease.
    Hashimoto H; Monserratt L; Nguyen P; Feil D; Harwood D; Mandelkern MA; Sultzer DL
    J Neuropsychiatry Clin Neurosci; 2006; 18(4):521-8. PubMed ID: 17135378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowly progressive aphasia without generalized dementia: studies with positron emission tomography.
    Chawluk JB; Mesulam MM; Hurtig H; Kushner M; Weintraub S; Saykin A; Rubin N; Alavi A; Reivich M
    Ann Neurol; 1986 Jan; 19(1):68-74. PubMed ID: 3484931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.